Dermatology 2013

2012/05/10 06:00

J Eur Acad Dermatol Venereol. 2013 Feb;27(2):133-41. doi: 10.1111/j.1468-3083.2012.04562.x. Epub 2012 May 8.

URL: http://www.ncbi.nlm.nih.gov/pubmed/22568407

Author Address: Department of Dermatology, Venereology and Allergy, Charite – University Medicine, Berlin, Germany. marcus.maurer@charite.de

 

 

Reference Type:  Journal Article

Record Number: 4496Author: Maurice, P. D., Fenton, T., Cross, N., Thomson, I. A., Rennie, S. C. and van Rij, A. M.

Year: 2013

Title: A dedicated dermatology clinic for renal transplant recipients: first 5 years of a New Zealand experience

Journal: N Z Med J

Volume: 126

Issue: 1369

Pages: 27-33

Date: Feb 15

Short Title: A dedicated dermatology clinic for renal transplant recipients: first 5 years of a New Zealand experience

Alternate Journal: The New Zealand medical journal

ISSN: 1175-8716 (Electronic)

0028-8446 (Linking)

Accession Number: 23463107

Keywords: Carcinoma, Basal Cell/diagnosis/*epidemiology

Carcinoma, Squamous Cell/diagnosis/*epidemiology

Causality

Cohort Studies

Comorbidity

Dermatology/organization & administration

Early Diagnosis

Female

Follow-Up Studies

Humans

Immunosuppression/adverse effects

Kidney Transplantation/*adverse effects/statistics & numerical data

Male

New Zealand

Postoperative Care/*methods/statistics & numerical data

Prognosis

Risk Factors

Skin Neoplasms/diagnosis/*epidemiology

Abstract: AIM: Cancer following organ transplantation is a growing public health concern. We describe the first 5 years’ experience of a dedicated dermatology clinic for renal transplant recipients, the first of its type in New Zealand. METHODS: Data from patients seen in the clinic were collected on a nephrology/dermatology database. RESULTS: 86 of 99 transplant recipients had a baseline dermatology assessment. Seventy-one skin cancers (45 squamous, 25 basal cell carcinomas, 1 melanoma) were found in 17 patients. Eighteen of these were an incidental finding at the baseline post-transplant examination of 7 patients: they had not been noted either by the patient or by their nephrologist. A further 44 cancers were found in 13 patients at follow-up examinations in the dedicated clinic. Squamous and basal cell carcinomas received definitive treatment after 26 and 38 days (median) respectively. A brief analysis showed this to be a cost-effective way of diagnosing and treating skin cancer in this cohort of patients. CONCLUSION: The clinic is enabling prompt diagnosis and cost-effective treatment of skin cancers developing in renal transplant recipients and is also identifying significant numbers of pre-existing skin cancers in these patients.

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295